We’re pleased to announce that Precision for Medicine is now a member of the Paris Saclay Cancer Cluster (PSCC). Combined with the renewal of our French CIR accreditation, it reinforces our position as a committed partner within the French life sciences landscape.
Proud to see our Frederick, MD team continue its support of Girls on the Run at this year’s “Celebrate Your Start” 5K, a partnership we’ve maintained since 2015. Our team, along with friends and family, enjoyed spending the morning together while celebrating personal milestones.
BriefGlance called it an FDA “Dream Team” for oncology trials. Precision for Medicine brings together 3 former FDA oncology leaders w/ deep experience across solid tumors, hematologic malignancies, biomarker strategy, novel endpoints & complex trial design https://t.co/7BOQltulaj
The Precision team will be onsite at the European Hematology Association Congress (EHA) this week to discuss how we are advancing clinical development and delivering smarter, more efficient solutions across hematology.
Seeking a Business Development Director (West Coast, US) eager to reach new heights and advance the development of life-changing treatments. https://t.co/hAa5cPRXNq
Patients with the same diagnosis can have different underlying biology, progression patterns & treatment responses. Traditional trial designs average that complexity out. If you get early assumptions wrong, every downstream decision gets harder. https://t.co/WJPGiRrqmg
Congratulations Gavin Phan from our Australian team on winning bronze in the Team Leader category of the PharmaTimes International Clinical Researcher of the Year 2026 Awards. Gavin's record of leadership and client service truly distinguishes him.
https://t.co/L89CSJCYWo
Running trials across the US, Europe, and APAC?
Precision’s in-region teams span 55+ countries delivering trusted site access, local expertise, and regulatory strength to accelerate global execution.
Let us smooth out your global trial.
https://t.co/ey7Gc58NfS
Verifying everything doesn’t mean everything gets verified.
SDV models are evolving with risk‑based, remote, hybrid... This article unpacks when to scale back, when to intensify, and how to tailor verification to quality minus waste: https://t.co/SN0kjYG664
Schedule time at ASCO Booth 10119 to talk early development, oncology strategy, and submission readiness with our expert operational team, including former regulators Harpreet Singh, MD, Nicholas Richardson, DO, MPH, and Paz Vellanki, MD, PhD.
Nearly 10% of Precision Trials Are Rescue Studies. When a Phase 1 biomarker-driven trial stalled under its first CRO, Precision stepped in. Sites activated ahead of expectations. First patient dosed immediately after screening.
https://t.co/usopPoNFfi
We’re proud to share that Vinitha Nair, Associate Director, Human Resources, was honored with the HR Leader of the Year award at the NexGen HR Tech Summit & Awards Conference. This recognition celebrates her outstanding leadership in advancing people and operational excellence.
New case study: How a true scientific partnership helped a diagnostic program grow and thrive. If you’re navigating early phase diagnostic development and need a partner who can grow with you, this story may resonate.
https://t.co/CRfuaHrJ5r
Getting ready for DIA China in Shanghai!
Here’s a sneak preview of the booth, and if you’re in Shanghai, we have plenty of experts and giveaways for you!
Are you responsible for navigating complexity across the development lifecycle? At the Clinical Trials Strategic Summit, Nicholas Richardson, DO will share a pragmatic view on turning early clinical insight into choices that stand up later, when the stakes are highest.
If you’re attending ASCO, discover what deep, real‑world oncology experience means for your program, from design through delivery.
Precision experts from around the world will be on hand to help kick‑start your planning. Connect with them: https://t.co/dMNDkCRZqW
Take on the challenge of changing lives. We’re seeking a Director, Project Management, Autoimmune ready to drive next-generation drug development: https://t.co/8ptLLpJVDQ
Report smart. Report fast. Clinical Study Reports need to be leaner, faster, and aligned with regulatory expectations. In this piece, our experts dig into how lean authoring practices trim time without trimming rigor: https://t.co/ASrxOvp4Je
Welcome Makoto Nishida, MS Pharmaceutical Science & Biochemistry, as Japan Country Manager & Executive Director, Project Management! Based in Tokyo, his initial focus will be to grow our clinical operations & commercial relationships in Japan as part of our APAC leadership team.